BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26288130)

  • 21. Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.
    Nejabati HR; Mota A; Farzadi L; Ghojazadeh M; Fattahi A; Hamdi K; Nouri M
    J Endocrinol Invest; 2017 Feb; 40(2):207-215. PubMed ID: 27664102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-selectin, resistin and reactive oxygen species levels in GnRH -agonist and -antagonist protocols in IVF/ICSI: a prospective cohort study.
    Siristatidis C; Askoxylaki M; Varounis C; Kassanos D; Chrelias C
    J Assist Reprod Genet; 2015 Jun; 32(6):959-67. PubMed ID: 25925352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
    Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
    Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein B is regulated by gonadotropins and constitutes a predictive biomarker of IVF outcomes.
    Scalici E; Bechoua S; Astruc K; Duvillard L; Gautier T; Drouineaud V; Jimenez C; Hamamah S
    Reprod Biol Endocrinol; 2016 May; 14(1):28. PubMed ID: 27209151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prokineticin 1 is a new biomarker of human oocyte competence: expression and hormonal regulation throughout late folliculogenesis.
    Alfaidy N; Baron C; Antoine Y; Reynaud D; Traboulsi W; Gueniffey A; Lamotte A; Melloul E; Dunand C; Villaret L; Bessonnat J; Mauroy C; Boueihl T; Coutton C; Martinez G; Hamamah S; Hoffmann P; Hennebicq S; Brouillet S
    Biol Reprod; 2019 Oct; 101(4):832-841. PubMed ID: 31276578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
    Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients.
    Younis JS; Jadaon JE; Haddad S; Izhaki I; Ben-Ami M
    Fertil Steril; 2011 Apr; 95(5):1754-8. PubMed ID: 21300343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular fluid humanin concentration is related to ovarian reserve markers and clinical pregnancy after IVF-ICSI: a pilot study.
    Rao M; Zhou F; Tang L; Zeng Z; Hu S; Wang Y; Ke D; Cheng G; Xia W; Zhang L; Zhu C
    Reprod Biomed Online; 2019 Jan; 38(1):108-117. PubMed ID: 30503199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PROK1 Level in the Follicular Microenvironment: A New Noninvasive Predictive Biomarker of Embryo Implantation.
    Alfaidy N; Hoffmann P; Gillois P; Gueniffey A; Lebayle C; Garçin H; Thomas-Cadi C; Bessonnat J; Coutton C; Villaret L; Quenard N; Bergues U; Feige JJ; Hennebicq S; Brouillet S
    J Clin Endocrinol Metab; 2016 Feb; 101(2):435-44. PubMed ID: 26401590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
    Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
    Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sperm DNA fragmentation on the clinical outcomes for in vitro fertilization and intracytoplasmic sperm injection in women with different ovarian reserves.
    Jin J; Pan C; Fei Q; Ni W; Yang X; Zhang L; Huang X
    Fertil Steril; 2015 Apr; 103(4):910-6. PubMed ID: 25747135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity and Clomiphene Challenge Test as predictors of outcome of in vitro fertilization and intracytoplasmic sperm injection.
    van Swieten EC; van der Leeuw-Harmsen L; Badings EA; van der Linden PJ
    Gynecol Obstet Invest; 2005; 59(4):220-4. PubMed ID: 15753618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation.
    Plati E; Kouskouni E; Malamitsi-Puchner A; Boutsikou M; Kaparos G; Baka S
    Fertil Steril; 2010 Sep; 94(4):1451-1456. PubMed ID: 19523615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perifollicular blood flow and its relationship with endometrial vascularity, follicular fluid EG-VEGF, IGF-1, and inhibin-a levels and IVF outcomes.
    Vural F; Vural B; Doğer E; Çakıroğlu Y; Çekmen M
    J Assist Reprod Genet; 2016 Oct; 33(10):1355-1362. PubMed ID: 27484063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.
    Yilmaz N; Uygur D; Dogan M; Ozgu E; Salman B; Mollamahmutoglu L
    Gynecol Endocrinol; 2012 Mar; 28(3):162-5. PubMed ID: 22103791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum and follicular fluid irisin levels in poor and high responder women undergoing IVF/ICSI.
    Acet M; Celik N; Acet T; Ilhan S; Yardim M; Aktun HL; Basaranoglu S; Deregozu A; Aydin S
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1940-6. PubMed ID: 27249590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.